William C Hunt
Overview
Explore the profile of William C Hunt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adcock R, Wheeler C, Hunt W, Torrez-Martinez N, Robertson M, McDonald R, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40069924
Background: Following human papillomavirus (HPV) vaccine introduction, declines in the prevalence of HPV vaccine types have been observed in screening cytology, but data from the United States describing HPV type-specific...
2.
Wheeler C, Adcock R, Hunt W, Robertson M, Torrez-Martinez N, McDonald R, et al.
J Natl Cancer Inst
. 2024 Dec;
PMID: 39658224
Background: Various studies have reported on the impact of human papillomavirus (HPV) vaccines. Here we present the largest population-based investigation of genotype-specific distributions over the decade following implementation of the...
3.
Castle P, Adcock R, Cuzick J, Wentzensen N, Torrez-Martinez N, Torres S, et al.
Arch Pathol Lab Med
. 2019 Nov;
144(6):725-734.
PMID: 31718233
Context.—: Lower Anogenital Squamous Terminology (LAST) standardization recommended p16 immunohistochemistry (p16 IHC) for biopsies diagnosed morphologically as cervical intraepithelial neoplasia (CIN) grade 2 (CIN2) to classify them as low-grade or...
4.
Adcock R, Cuzick J, Hunt W, McDonald R, Wheeler C
Cancer Epidemiol Biomarkers Prev
. 2019 Sep;
28(11):1816-1824.
PMID: 31488417
Background: Human papillomavirus (HPV) testing provides a much more sensitive method of detection for high-grade lesions than cytology, but specificity is low. Here, we explore the extent to which full...
5.
Cuzick J, Myers O, Lee J, Shi Y, Gage J, Hunt W, et al.
JAMA Oncol
. 2017 Jun;
3(10):1327-1334.
PMID: 28655061
Importance: Little is known about the long-term yield of high-grade cervical intraepithelial neoplasia (CIN) and the influence on biopsy and treatment rates of human papillomavirus (HPV) triage of cytology showing...
6.
Chumlea W, Rhyne R, Garry P, Hunt W
Am J Hum Biol
. 2017 May;
1(4):457-462.
PMID: 28514105
Changes in body composition are known to occur with old age, but there is limited knowledge of the normal values rates of change in anthropometric indices of body composition or...
7.
Gage J, Hunt W, Schiffman M, Katki H, Cheung L, Myers O, et al.
Obstet Gynecol
. 2016 Nov;
128(6):1248-1257.
PMID: 27824767
Objective: To compare the risks of histologic high-grade cervical intraepithelial neoplasia (CIN) or worse after different cervical cancer screening test results between two of the largest U.S. clinical practice research...
8.
Benard V, Castle P, Jenison S, Hunt W, Kim J, Cuzick J, et al.
JAMA Oncol
. 2016 Sep;
3(6):833-837.
PMID: 27685805
Importance: A substantial effect of human papillomavirus (HPV) vaccines on reducing HPV-related cervical disease is essential before modifying clinical practice guidelines in partially vaccinated populations. Objective: To determine the population-based...
9.
Gage J, Joste N, Ronnett B, Stoler M, Hunt W, Schiffman M, et al.
Hum Pathol
. 2016 May;
52:201.
PMID: 27141825
No abstract available.
10.
Gage J, Hunt W, Schiffman M, Katki H, Cheung L, Cuzick J, et al.
Cancer Epidemiol Biomarkers Prev
. 2015 Nov;
25(1):36-42.
PMID: 26518316
Background: Clinical guidelines for cervical cancer screening have incorporated comparative risks of cervical intraepithelial neoplasia grade 3 or cancer (CIN3(+)) for various screening outcomes to determine management. Few cohorts are...